NIH-funded research R01 grant

Instagram group program to help teens quit vaping

Official title: Social media support groups for adolescent vaping cessation

Funded at University of California, San Francisco · NIH-11189773 · Data updated 2026-11-12

This program uses Instagram direct-message groups to help teens and young adults (ages 13–21) stop using e-cigarettes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 9, 2024
Project endAugust 31, 2029
Funding year2025
Award (this year)$676,818
NIH project number5R01CA292971-02
Project IDNIH-11189773 on NIH RePORTER

Who could benefit from this research

Could help

Teens and young adults aged 13–21 who currently use e-cigarettes and are willing to join and use Instagram group messaging are ideal candidates.

Less likely to help

Teens under 13, people without an Instagram account or unwilling to engage in group messaging, or those not ready to quit vaping may not receive benefit from this program.

What this research studies

If I join the 'Quit the Hit' program, I'll be placed in a small Instagram direct-message group with other teens for peer support and quitting tips. The program was co-created with hundreds of adolescents and has already been tested in a randomized trial with promising preliminary results. It focuses on mid-to-late adolescents aged 13–21 and uses messaging and moderated peer interaction rather than in-person visits. The whole program is delivered through Instagram, making participation flexible and scalable.

Why it matters

Potential benefit: If successful, this could help more teens quit vaping, reduce vaping-related health risks like asthma and heart effects, and reach many young people through social media.

How similar studies have gone: Few vaping cessation programs exist for adolescents and none have been widely delivered via social media, but this program's preliminary randomized trial data show higher short-term abstinence, making it a promising new approach.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Ling, Pamela May — University of California, San Francisco
  • Study coordinator: Ling, Pamela May

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.